China Digest: Medbanks nabs $59m Series D; Shenzhen Lihexing snags $19m

China Digest: Medbanks nabs $59m Series D; Shenzhen Lihexing snags $19m

T-lymphocytes attack a migrating cancer cell. Visual from Medisix's website.

CDH Investments.CLP fundCowin CapitalShenzhen Capital Fortune Investment ManagementShenzhen Lihexing

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.